- Home
- EOSE vs ABCL Comparison
EOSE vs ABCL Comparison
Compare EOSE & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- ABCL
- Stock Information
- Founded
- EOSE 2008
- ABCL 2012
- Country
- EOSE United States
- ABCL Canada
- Employees
- EOSE N/A
- ABCL N/A
- Industry
- EOSE Industrial Machinery/Components
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- EOSE Miscellaneous
- ABCL Health Care
- Exchange
- EOSE Nasdaq
- ABCL Nasdaq
- Market Cap
- EOSE 1.3B
- ABCL 1.1B
- IPO Year
- EOSE N/A
- ABCL 2020
- Fundamental
- Price
- EOSE $4.63
- ABCL $4.01
- Analyst Decision
- EOSE Strong Buy
- ABCL Strong Buy
- Analyst Count
- EOSE 3
- ABCL 5
- Target Price
- EOSE $22.83
- ABCL $7.50
- AVG Volume (30 Days)
- EOSE 13.2M
- ABCL 6.8M
- Earning Date
- EOSE 08-05-2025
- ABCL 08-07-2025
- Dividend Yield
- EOSE N/A
- ABCL N/A
- EPS Growth
- EOSE N/A
- ABCL N/A
- EPS
- EOSE N/A
- ABCL N/A
- Revenue
- EOSE $19,462,000.00
- ABCL $23,114,000.00
- Revenue This Year
- EOSE $945.82
- ABCL N/A
- Revenue Next Year
- EOSE $195.86
- ABCL $67.99
- P/E Ratio
- EOSE N/A
- ABCL N/A
- Revenue Growth
- EOSE 37.60
- ABCL N/A
- 52 Week Low
- EOSE $1.40
- ABCL $1.89
- 52 Week High
- EOSE $7.36
- ABCL $4.33
- Technical
- Relative Strength Index (RSI)
- EOSE 48.33
- ABCL 65.36
- Support Level
- EOSE $4.20
- ABCL $3.28
- Resistance Level
- EOSE $5.48
- ABCL $4.33
- Average True Range (ATR)
- EOSE 0.33
- ABCL 0.30
- MACD
- EOSE 0.04
- ABCL 0.02
- Stochastic Oscillator
- EOSE 34.62
- ABCL 71.17
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.